Possibility and prospects of using colchicine in patients with COVID-19, review update

DOI: https://dx.doi.org/10.18565/pharmateca.2021.2.8-11

Yu.Yu. Kiselev (1), A.V. Matveev (2)

1) Oslo Metropolitan University, Norway, https://orcid.org/0000-0002-6753-8572; 2) Russian Medical Academy of Continuous Professional Education, Moscow, Russia, https://orcid.org/0000-0002-6636-3950
There are theoretical prerequisites for the use of colchicine in the treatment of patients with COVID-19, and clinical studies are underway. To date, there is only limited published data indicating the potential efficacy of colchicine for COVID-19. These data do not yet allow to recommend it for general practice. When using colchicine, it is important to perform clinical and hematologic control and avoid drug interactions.
Keywords: COVID-19, colchicine

Бионика Медиа